StockVS

HCM III Acquisition Corp. (HCMA) 股票分析

金融服务

HCM III Acquisition Corp.

$10.24

+$0.02 (+0.20%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

HCM III Acquisition Corp. operates primarily as a shell company dedicated to effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The entity is classified within the Financial Services sector and specifically functions in the Shell Companies industry, a classification that denotes its current status as a special purpose acquisition vehicle awaiting a target rather than an operating business with established products or services. As of the latest available data, the company maintains a market capitalization of $341.04M, while its annual revenue and total employee count are not publicly disclosed in the current reporting period. The stated market cap of $341.04M indicates a mid-sized valuation typical for SPACs in the post-merger phase or those that have recently completed a business combination but have not yet generated significant operating revenue streams.

财务健康

The company reports a net income of $2.92M over the trailing twelve months, whereas its revenue, EBITDA, and free cash flow are currently not available for public reporting. The existence of positive net income alongside unavailable revenue figures suggests a cost structure where non-operating income or specific transaction-related gains may be driving profitability before the underlying operating revenue metrics are fully realized or reported. Gross margin, operating margin, and profit margin are all recorded at 0.0%, which reflects the transitional nature of shell companies that often do not yet incur significant operating expenses relative to revenue or report revenue only upon specific transaction completions. The balance sheet shows a cash position of $1.02M with zero total debt, creating a scenario where the company holds liquidity without any leverage obligations. Although the debt-to-equity ratio is not explicitly calculated due to the absence of equity or debt data in standard metrics, the presence of cash and zero debt indicates a highly conservative balance sheet structure with no interest burden. The current ratio stands at 1.64, which indicates that the company possesses sufficient current assets to cover its short-term liabilities with a comfortable margin of safety. Return on equity and return on assets are not available for calculation at this time, meaning that management effectiveness cannot yet be gauged through traditional return metrics until the company transitions into a revenue-generating operational model.

估值评估

The trailing P/E ratio and forward P/E ratio are both not available, which implies that traditional earnings-based valuation models cannot currently be applied to assess expected earnings trajectories or growth expectations for this specific entity. The price-to-book ratio is reported at -7.32, a negative figure that indicates the market valuation is significantly below the book value of equity, a phenomenon common for shell companies where book value may include historical capital that does not reflect current market realities or where equity structure is complex. The price-to-sales ratio and EV/EBITDA are also not available, suggesting that alternative valuation metrics relying on revenue multiples or enterprise value relative to earnings are not currently applicable due to the lack of reported sales or EBITDA figures. The 52-week high is recorded at $10.49 and the 52-week low at $10.03, placing the current trading range within a very narrow band of just 46 cents. This narrow trading range suggests low volatility in the immediate price action, with the stock trading at the lower end of its annual historical range relative to the 52-week high. The beta value is not available, so no definitive statement can be made regarding the stock's price volatility relative to the broader market based on the current data set.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are not available, preventing a direct comparison of whether earnings are growing faster or slower than revenue at this specific point in the company's lifecycle. Since the company does not pay dividends, there is no dividend yield or payout ratio to analyze for sustainability, which confirms that the entity reinvests its earnings or utilizes its cash reserves into growth initiatives such as identifying and executing a business combination rather than distributing income to shareholders. The overall growth and income profile is characterized by the absence of historical growth metrics and dividend payments, typical for a special purpose acquisition vehicle focused on capital deployment for mergers rather than organic expansion or income generation. This structural profile indicates that value creation is contingent entirely upon the successful identification and execution of a merger target, rather than reliance on existing business performance or dividend income streams.

同行比较

HCM III Acquisition Corp. (HCMA) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
HCM III Acquisition Corp. HCMA $345.43M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。HCM III Acquisition Corp.的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于HCM III Acquisition Corp.

HCM III Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. HCM III Acquisition Corp. was incorporated in 2025 and is based in Norwalk, Connecticut.

公司简介以英文显示。

关键指标

市值
$345.43M
市盈率
N/A
52周最高
$10.49
52周最低
$10.03
平均成交量
11.65K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States